Cargando…

P19-31. Neutralizing antibodies specific for the transmembrane envelope proteins of gammaretroviruses and of HIV-1 (2F5, 4E10): comparison of their action

Detalles Bibliográficos
Autores principales:	Eschricht, M, Fiebig, U, Kurth, R, Denner, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767861/ http://dx.doi.org/10.1186/1742-4690-6-S3-P351

Ejemplares similares

Immunisation with the membrane proximal external region of gp41 of HIV-1 grafted into the transmembrane envelope protein of a gammaretrovirus
por: Strasz, N, et al.
Publicado: (2012)

Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA
por: Fiebig, Uwe, et al.
Publicado: (2015)

Functional analyses of glycosylated gag molecules derived from different gammaretroviruses
por: Cuccurullo, Emilia Cristiana, et al.
Publicado: (2013)

The transmembrane envelope protein of HIV-1 and other retroviruses modulate cytokine production and induce Treg cells
por: Behrendt, Rayk, et al.
Publicado: (2006)

Detection of a gammaretrovirus, XMRV, in the human population: Open questions and implications for xenotransplantation
por: Denner, Joachim
Publicado: (2010)

Mouse "xenotropic" gammaretroviruses, XMRV and their XPR1 receptor
por: Baliji, Surendranath, et al.
Publicado: (2011)

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone
por: Malherbe, DC, et al.
Publicado: (2009)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope
por: Hioe, CE, et al.
Publicado: (2009)

Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits
por: Malherbe, DC, et al.
Publicado: (2012)

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
por: Basavapathruni, A, et al.
Publicado: (2009)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Transspecies Transmission of Gammaretroviruses and the Origin of the Gibbon Ape Leukaemia Virus (GaLV) and the Koala Retrovirus (KoRV)
por: Denner, Joachim
Publicado: (2016)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
por: Rong, R, et al.
Publicado: (2009)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
por: Matyas, GR, et al.
Publicado: (2009)

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
por: van den Kerkhof, Tom, et al.
Publicado: (2011)

Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1
por: Morozov, Vladimir A, et al.
Publicado: (2012)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
por: Xu, H, et al.
Publicado: (2009)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
por: van den Kerkhof, TL, et al.
Publicado: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
por: Archary, D, et al.
Publicado: (2012)

The mouse "xenotropic" gammaretroviruses and their XPR1 receptor
por: Kozak, Christine A
Publicado: (2010)

Origins of the Endogenous and Infectious Laboratory Mouse Gammaretroviruses
por: Kozak, Christine A.
Publicado: (2014)

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
por: Czernekova, Lydie, et al.
Publicado: (2014)

Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs)
por: Denner, Joachim, et al.
Publicado: (2012)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8
por: Yu, X, et al.
Publicado: (2012)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
por: London, GG, et al.
Publicado: (2012)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
por: Jacob, RA, et al.
Publicado: (2012)

P12-10. Immunogen utilizing the stable interaction of cytoplasmic tails of HIV-1 envelope and cores
por: Takahashi, H, et al.
Publicado: (2009)

Nuclear envelope laminopathies: evidence for developmentally inappropriate chromatin-nuclear envelope interactions
por: Perovanovic, Jelena, et al.
Publicado: (2013)

Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
por: Fouda, GG, et al.
Publicado: (2012)

Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
por: Lambert, Caroline A, et al.
Publicado: (2015)

Targeting HIV-1 envelope glycoprotein trimers to B cells using APRIL improves antibody responses
por: Melchers, M, et al.
Publicado: (2012)

Antibody responses to V2 loop are induced by CRF01_A E and not Clade B envelopes
por: Karasavvas, N, et al.
Publicado: (2012)

The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody
por: Tudor, Daniela, et al.
Publicado: (2010)

P19-12. Multimers of llama heavy chain variable domains that bind to the 2F5/4E10 epitope neutralize HIV-1
por: Liu, Y, et al.
Publicado: (2009)

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate
por: Chung, H, et al.
Publicado: (2009)

P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape
por: Moore, PL, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0g3477aas59o7mnok306q2sktk